Page last updated: 2024-08-24

liarozole and Dermatitis

liarozole has been researched along with Dermatitis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akira, S; Amiya, T; Fujisawa, K; Hashimoto, E; Kabashima, K; Kiyono, H; Kogure, Y; Kubo, M; Kunisawa, J; Kurashima, Y; Miyake, K; Otsuka, A; Sato, S; Sato, T; Shibata, N; Suzuki, Y1

Other Studies

1 other study(ies) available for liarozole and Dermatitis

ArticleYear
The enzyme Cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis.
    Immunity, 2014, Apr-17, Volume: 40, Issue:4

    Topics: Adenosine Triphosphate; Animals; Cell Degranulation; Cytochrome P-450 Enzyme System; Dermatitis; Fibroblasts; Imidazoles; Immunity, Innate; Mast Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Microbiota; Receptors, Purinergic P2X7; Retinoic Acid 4-Hydroxylase; Skin; Toll-Like Receptor 2; Tretinoin

2014